On June 3, Gelun Hui reported that Zhejiang Orient Gene Biotech (stock code 688298.SH) announced that as of May 31, 2024, the company had repurchased a cumulative total of 8.3327 million shares of the company's shares through the Shanghai Stock Exchange's centralized bidding trading method, accounting for 4.13% of the company's total share capital of 201.6 million shares. The lowest price for repurchase transactions was 27.83 yuan/share, the highest price was 34.50 yuan/share, and the total amount paid was 275 million yuan.
东方生物(688298.SH)：累计回购4.13%公司股份
Zhejiang Orient Gene Biotech(688298.SH): Cumulative buyback of 4.13% of the company's shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.